Signs of severe dehydration (dark urine, sunken eyes, and rapid heartbeat) Hypoglycemia (low blood sugar levels) occurs when retatrutide is used with other glucose-lowering medications
Pharmacy quality systems exist to catch them
When to seek medical advice : Patients should contact their GP, diabetes specialist nurse, or NHS 111 urgently if they experience: Severe, persistent abdominal pain, especially if radiating to the back (possible pancreatitis) Persistent vomiting (unable to keep down fluids for more than 24 hours) Signs of dehydration (extreme thirst, dry mouth, reduced urination, dizziness) Fever, jaundice, or right upper abdominal pain (possible gallbladder disease) If nausea significantly impacts their ability to maintain adequate nutrition These symptoms may warrant dose reduction, temporary treatment interruption, or switching to an alternative GLP-1 preparation with a potentially better tolerability profile
This is NOT seen with semaglutide or tirzepatide and is likely related to glucagon receptor activation or rapid metabolic changes
One of the most common questions people ask before starting a GLP-1 medication is also one of the most hones
